Stocks and Investing
Stocks and Investing
Fri, March 31, 2023
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
Thu, March 30, 2023
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
Kristen Kluska Maintained (TSHA) at Buy with Decreased Target to $2 on, Mar 30th, 2023
Kristen Kluska of Cantor Fitzgerald, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Decreased Target from $13 to $2 on, Mar 30th, 2023.
Kristen has made no other calls on TSHA in the last 4 months.
There are 8 other peers that have a rating on TSHA. Out of the 8 peers that are also analyzing TSHA, 3 agree with Kristen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yun Zhong of "BTIG" Downgraded from Strong Buy to Hold on, Thursday, February 2nd, 2023
- Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $1.5 on, Wednesday, February 1st, 2023
- Michael Ulz of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $3 on, Friday, January 27th, 2023
These are the ratings of the 5 analyists that currently disagree with Kristen
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $6 on, Wednesday, March 29th, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $3 on, Wednesday, March 29th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $13 on, Wednesday, February 1st, 2023
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $6 on, Wednesday, February 1st, 2023
- Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $10 on, Wednesday, January 4th, 2023
Contributing Sources